We are live on ! Find out more
DA

DSC Advisors Portfolio holdings

AUM $11M
1-Year Est. Return 5.88%
This Fund
S&P 500
This Quarter Est. Return
+20.48%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$121M
AUM Growth
-$28.5M
Cap. Flow
-$63.2M
Cap. Flow %
-52.25%
Top 10 Hldgs %
80.64%
Holding
61
New
15
Increased
3
Reduced
25
Closed
13

Top Buys

1
EHTH icon
eHealth
EHTH
+$1.98M
2
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
+$916K
3
JAMF
Jamf
JAMF
+$660K
4
CELU icon
Celularity
CELU
+$531K
5
ZM icon
Zoom
ZM
+$405K

Top Sells

1
BMY icon
Bristol-Myers Squibb
BMY
+$15.4M
2
HMSY
HMS Holdings Corp.
HMSY
+$599K
3
SLV icon
iShares Silver Trust
SLV
+$569K
4
XYZ
Block Inc
XYZ
+$307K
5
ACN icon
Accenture
ACN
+$273K

Sector Composition

1 Healthcare 27.24%
2 Financials 27.15%
3 Communication Services 17.57%
4 Technology 7.49%
5 Consumer Discretionary 0.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOOG icon
1
Alphabet (Google) Class C
GOOG
$4.22T
$18M 14.92%
206,000
– –
QQQ icon
2
PUT
Invesco QQQ Trust
QQQ
$466B
$15.7M 12.97%
50,000
-150,000
-75% -$44M
ATH
3
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$14.4M 11.88%
333,000
– –
MS icon
4
Morgan Stanley
MS
$339B
$13.2M 10.91%
192,473
+59
+0% +$3.38K
ALXN
5
DELISTED
Alexion Pharmaceuticals
ALXN
$10.8M 8.91%
69,000
– –
CVS icon
6
CVS Health
CVS
$137B
$9.04M 7.47%
132,338
-266
-0.2% -$17.3K
VYNE icon
7
VYNE Therapeutics
VYNE
$25.4M
$6.56M 5.42%
57,675
– –
CVS icon
8
CALL
CVS Health
CVS
$137B
$4.17M 3.44%
61,000
– –
BMY icon
9
Bristol-Myers Squibb
BMY
$124B
$3.76M 3.11%
60,655
-249,787
-80% -$15.4M
DVA icon
10
DaVita
DVA
$15.2B
$1.94M 1.6%
16,500
-2,500
-13% -$255K
EHTH icon
11
eHealth
EHTH
$47.3M
$1.84M 1.52%
+26,000
New +$1.98M
SLV icon
12
CALL
iShares Silver Trust
SLV
$27.1B
$1.23M 1.02%
+50,000
New +$1.14M
MSFT icon
13
Microsoft
MSFT
$2.93T
$1.19M 0.98%
5,344
-74
-1% -$15.9K
GOOGL icon
14
Alphabet (Google) Class A
GOOGL
$4.23T
$1.14M 0.94%
13,020
-1,980
-13% -$167K
META icon
15
Meta Platforms (Facebook)
META
$1.64T
$1.06M 0.87%
3,874
-168
-4% -$46.1K
PYPL icon
16
PayPal
PYPL
$49.9B
$1.02M 0.84%
4,340
-554
-11% -$115K
V icon
17
Visa
V
$682B
$1.01M 0.83%
4,602
-338
-7% -$69.2K
MA icon
18
Mastercard
MA
$480B
$1M 0.83%
2,812
-82
-3% -$27.3K
NFLX icon
19
Netflix
NFLX
$290B
$1M 0.83%
18,530
-210
-1% -$10.6K
ADBE icon
20
Adobe
ADBE
$94.3B
$952K 0.79%
1,903
-49
-3% -$23.7K
CRM icon
21
Salesforce
CRM
$140B
$825K 0.68%
3,706
+52
+1% +$12.6K
AAPL icon
22
Apple
AAPL
$4.9T
$755K 0.62%
5,692
-309
-5% -$37.2K
ACN icon
23
Accenture
ACN
$87.9B
$738K 0.61%
2,826
-1,140
-29% -$273K
EHTH icon
24
CALL
eHealth
EHTH
$47.3M
$706K 0.58%
+10,000
New +$760K
SLV icon
25
PUT
iShares Silver Trust
SLV
$27.1B
$614K 0.51%
+25,000
New +$569K
1
2 3

Similar funds

RJTCONH
Raymond James Trust Company of New Hampshire Portsmouth, New Hampshire $12.1M AUM 28.84% 1-Year Est. Return
HSC
Harbor Spring Capital New York $12.3M AUM
BGC
Birch Grove Capital New York $9.51M AUM 0.22% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
AG
Arctis Global San Juan, Puerto Rico $14.5M AUM 58.16% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
JDR
Jay D. Rosenbaum $6.69M AUM 4.68% 1-Year Est. Return
KM
Kabouter Management Chicago, Illinois $15.6M AUM 16.79% 1-Year Est. Return

DSC Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, DSC Advisors held 61 positions worth $121M, down 19% from $149M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

DSC Advisors withdrew a net $63.2M in Q4 2020, closing 13 positions and reducing 25 holdings. Its most notable exit was HMS Holdings Corp., an estimated $599K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 20% a quarter earlier, followed by Financials and Communication Services.

Against the trend, DSC Advisors opened a new position in eHealth worth $1.84M.

  • DSC Advisors's largest Q4 2020 buy was eHealth: 26,000 shares worth $1.84M.
  • DSC Advisors added most to Amazon in Q4 2020, an estimated $28.7K increase.
  • DSC Advisors's biggest Q4 2020 reduction was Bristol-Myers Squibb, cutting an estimated $15.4M.
  • DSC Advisors fully exited HMS Holdings Corp. in Q4 2020, selling an estimated $599K.
  • DSC Advisors's ten largest holdings make up 81% of its $121M portfolio in Q4 2020.
  • DSC Advisors opened 15 new positions and closed 13 in Q4 2020.
  • DSC Advisors's portfolio value fell 19% quarter-over-quarter to $121M.

Based on DSC Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.